MEDSTONE STS LITHOTRIPTER FOR THE TREATMENT OF SYMPTOMATIC, SOLITARY, RADIOLUCENT, NON-CALCIFIED GALLSTONES

Lithotripter, Shockwave (for Treating Gallbladder Stones)

FDA Premarket Approval P970042 S004

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for 1) a change in the inclusion age limit for the post-approval study from 18-70 to 18 and over; 2) a change in the post approval study's monitoring from rsi to medstone; and 3) a change in the post-approval study's medical monitor from rsi to michael albert, m. D.

DeviceMEDSTONE STS LITHOTRIPTER FOR THE TREATMENT OF SYMPTOMATIC, SOLITARY, RADIOLUCENT, NON-CALCIFIED GALLSTONES
Classification NameLithotripter, Shockwave (for Treating Gallbladder Stones)
Generic NameLithotripter, Shockwave (for Treating Gallbladder Stones)
ApplicantMEDSTONE INTL., INC.
Date Received2002-08-02
Decision Date2003-01-28
PMAP970042
SupplementS004
Product CodeNCV
Advisory CommitteeGastroenterology/Urology
Supplement TypeNormal 180 Day Track
Supplement ReasonPostapproval Study Protocol - Ode/oir
Expedited ReviewNo
Combination Product Yes
Applicant Address MEDSTONE INTL., INC. 100 Columbia, Suite 100 aliso Viejo, CA 92656-4114

Supplemental Filings

Supplement NumberDateSupplement Type
P970042Original Filing
S004 2002-08-02 Normal 180 Day Track
S003 2002-07-03 Normal 180 Day Track
S002 2002-02-21 Normal 180 Day Track
S001 2000-12-18 Normal 180 Day Track

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.